Halo Labs Completes $6M Series C Growth Financing

By WebmasterJuly 11, 2022November 1st, 2024No Comments

Halo Labs Completes $6M Series C Growth Financing

Previous PostRenovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
Next PostAnnovis Bio Announces Positive FDA Notice For Buntanetap Phase 3 Clinical Trial In Parkinson's Disease